Search Constraints
« Previous |
41 - 60 of 80
|
Next »
Search Results
Select an image to start the slideshow
Development of lysine-targeted irreversible inhibitors of PI3Kδ
1 of 20
The design and synthesis of αvβ6 antagonists and PI3K inhibitors as small molecule therapies for respiratory diseases
2 of 20
Novel PI3Kδ inhibitors for the treatment of inflammatory diseases
3 of 20
Use of fragment-based drug discovery to identify novel drug molecules for challenging biological targets, including protein-protein interactions
4 of 20
Studies towards the synthesis and labelling of bioactive peptides
5 of 20
The design and synthesis of probe molecules to validate the inhibition of epigenetic mechanisms for phenotypic responses
6 of 20
Development towards prospective modelling of in vivo rabbit QTc prolongation
7 of 20
Chan-Lam animation studies : solving the chemotype reactivity issue
8 of 20
Chemoselective C-H functionalisation of aliphatic azacycles : utilisation of electrophilic iodine as a mild oxidant
9 of 20
Investigation and application of 3-Oxabicyclo[4.1.0]heptane as a mechanistic target of rapamycin (mTOR) kinase hinge binding fragment
10 of 20
The application of flow chemistry to the synthesis of pharmaceutically privileged heterocycles
11 of 20
Iron-catalysed cross-couplings of secondary alkyl Grignard reagents
12 of 20
Computational modelling of enzyme activity to speed up biocatalyst redesign
13 of 20
Increasing the saturation of BET inhibitors
14 of 20
Understanding reaction mechanisms and structure/reactivity relationships in the electrophilic fluorination of enol esters
15 of 20
The development of small molecules for treatment of idiopathic pulmonary fibrosis (IPF)
16 of 20
The design and synthesis of small molecule bromodomain inhibitors
17 of 20
Pharmacological characterisation of the 5-HT receptors present on mouse and human hepatic stellate cells and their role in liver fibrosis
18 of 20
Investigating and exploiting best practices in hit identification and hit to lead chemistry
19 of 20
Structure-guided approaches to the design of novel autotaxin inhibitors
20 of 20